Mylan And Pfizer Announce Key Date For Viatris Merger

Follows Delay Due To Coronavirus Pandemic

MylanOffice
The latest move in Mylan and Upjohn's protracted bid to merge into Viatris has been disclosed • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business